These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36527474)

  • 21. DHA substitution overcomes high-fat diet-induced disturbance in the circadian rhythm of lipid metabolism.
    Chen R; Zuo Z; Li Q; Wang H; Li N; Zhang H; Yu X; Liu Z
    Food Funct; 2020 Apr; 11(4):3621-3631. PubMed ID: 32292967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target.
    Smati S; Polizzi A; Fougerat A; Ellero-Simatos S; Blum Y; Lippi Y; Régnier M; Laroyenne A; Huillet M; Arif M; Zhang C; Lasserre F; Marrot A; Al Saati T; Wan J; Sommer C; Naylies C; Batut A; Lukowicz C; Fougeray T; Tramunt B; Dubot P; Smith L; Bertrand-Michel J; Hennuyer N; Pradere JP; Staels B; Burcelin R; Lenfant F; Arnal JF; Levade T; Gamet-Payrastre L; Lagarrigue S; Loiseau N; Lotersztajn S; Postic C; Wahli W; Bureau C; Guillaume M; Mardinoglu A; Montagner A; Gourdy P; Guillou H
    Gut; 2022 Apr; 71(4):807-821. PubMed ID: 33903148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice.
    Kondo K; Sugioka T; Tsukada K; Aizawa M; Takizawa M; Shimizu K; Morimoto M; Suematsu M; Goda N
    Adv Exp Med Biol; 2010; 662():77-82. PubMed ID: 20204774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
    Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis.
    Qiu H; Song E; Hu Y; Li T; Ku KC; Wang C; Cheung BMY; Cheong LY; Wang Q; Wu X; Hoo RLC; Wang Y; Xu A
    Cell Mol Gastroenterol Hepatol; 2022; 14(5):1003-1023. PubMed ID: 35931383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRDX6 Promotes Fatty Acid Oxidation
    Shen W; Yang L; Yang Y; Wang P; Tao X; Shen Y; Wang S; Shen Y
    Antioxid Redox Signal; 2023 Jun; 38(16-18):1184-1200. PubMed ID: 36401357
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity.
    Régnier M; Polizzi A; Smati S; Lukowicz C; Fougerat A; Lippi Y; Fouché E; Lasserre F; Naylies C; Bétoulières C; Barquissau V; Mouisel E; Bertrand-Michel J; Batut A; Saati TA; Canlet C; Tremblay-Franco M; Ellero-Simatos S; Langin D; Postic C; Wahli W; Loiseau N; Guillou H; Montagner A
    Sci Rep; 2020 Apr; 10(1):6489. PubMed ID: 32300166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARα suppresses low-intensity-noise-induced body weight gain in mice: the activated HPA axis plays an critical role.
    Yan Z; Luo J; Wang Y; Yang J; Su M; Jiang L; Yang J; Dai M; Liu A
    Int J Obes (Lond); 2024 Sep; 48(9):1274-1282. PubMed ID: 38902386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
    Front Immunol; 2020; 11():148. PubMed ID: 32158445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet.
    Luo Z; Li M; Yang Q; Zhang Y; Liu F; Gong L; Han L; Wang M
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease.
    Yu DD; Van Citters G; Li H; Stoltz BM; Forman BM
    Bioorg Med Chem; 2021 Jul; 41():116193. PubMed ID: 34022528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα.
    Wei X; Zhang J; Tang M; Wang X; Fan N; Peng Y
    Lipids Health Dis; 2022 Mar; 21(1):29. PubMed ID: 35282837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary fenofibrate attenuated high-fat-diet-induced lipid accumulation and inflammation response partly through regulation of pparα and sirt1 in juvenile black seabream (Acanthopagrus schlegelii).
    Jin M; Zhu T; Tocher DR; Luo J; Shen Y; Li X; Pan T; Yuan Y; Betancor MB; Jiao L; Sun P; Zhou Q
    Dev Comp Immunol; 2020 Aug; 109():103691. PubMed ID: 32251698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice.
    Bi X; Liu W; Xia X; Chen L; Mu T; Liu J; Hou Y; Zhao Y
    Food Funct; 2014 Dec; 5(12):3304-10. PubMed ID: 25367327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.